{
  "fullName": "Michael Hallek",
  "slug": "michael-hallek",
  "title": "MD",
  "specialty": "Hematology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 123,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. In CLL, the bone marrow produces too many lymphocytes, which are a type of white blood cell. B cell lymphocytes can begin to collect in the blood, spleen, lymph nodes, and bone marrow; these cells malfunction and crowd out healthy blood cells. CLL is divided into slow-growing (indolent) and fast-growing variants.",
  "aiSummary": "Michael Hallek is a hematology specialist with an H-index of 123 at University of Cologne (Member). Has been published in Nature, The Lancet, New England Journal of Medicine. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "University of Cologne"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "University of Cologne",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Hematology"
  ],
  "knowsAbout": [
    "German Cancer Award"
  ],
  "citations": [
    {
      "title": "Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines",
      "journal": "Blood",
      "year": 2008,
      "citationCount": 3173,
      "doi": "10.1182/blood-2007-06-093906",
      "sourceUrl": "https://doi.org/10.1182/blood-2007-06-093906",
      "verified": true
    },
    {
      "title": "Comprehensive genomic profiles of small cell lung cancer",
      "journal": "Nature",
      "year": 2015,
      "citationCount": 2291,
      "doi": "10.1038/nature14664",
      "sourceUrl": "https://doi.org/10.1038/nature14664",
      "verified": true
    },
    {
      "title": "Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial",
      "journal": "The Lancet",
      "year": 2010,
      "citationCount": 1857,
      "doi": "10.1016/s0140-6736(10)61381-5",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(10)61381-5",
      "verified": true
    },
    {
      "title": "Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia",
      "journal": "New England Journal of Medicine",
      "year": 2014,
      "citationCount": 1672,
      "doi": "10.1056/nejmoa1315226",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1315226",
      "verified": true
    },
    {
      "title": "iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL",
      "journal": "Blood",
      "year": 2018,
      "citationCount": 1609,
      "doi": "10.1182/blood-2017-09-806398",
      "sourceUrl": "https://doi.org/10.1182/blood-2017-09-806398",
      "verified": true
    },
    {
      "title": "Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions",
      "journal": "New England Journal of Medicine",
      "year": 2014,
      "citationCount": 1476,
      "doi": "10.1056/nejmoa1313984",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1313984",
      "verified": true
    },
    {
      "title": "Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer",
      "journal": "Nature Genetics",
      "year": 2012,
      "citationCount": 1399,
      "doi": "10.1038/ng.2396",
      "sourceUrl": "https://doi.org/10.1038/ng.2396",
      "verified": true
    },
    {
      "title": "Mutations driving CLL and their evolution in progression and relapse",
      "journal": "Nature",
      "year": 2015,
      "citationCount": 1037,
      "doi": "10.1038/nature15395",
      "sourceUrl": "https://doi.org/10.1038/nature15395",
      "verified": true
    },
    {
      "title": "Real-Time Single-Molecule Imaging of the Infection Pathway of an Adeno-Associated Virus",
      "journal": "Science",
      "year": 2001,
      "citationCount": 824,
      "doi": "10.1126/science.1064103",
      "sourceUrl": "https://doi.org/10.1126/science.1064103",
      "verified": true
    },
    {
      "title": "Frequent and Focal <i>FGFR1</i> Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer",
      "journal": "Science Translational Medicine",
      "year": 2010,
      "citationCount": 818,
      "doi": "10.1126/scitranslmed.3001451",
      "sourceUrl": "https://doi.org/10.1126/scitranslmed.3001451",
      "verified": true
    },
    {
      "title": "Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions",
      "journal": "New England Journal of Medicine",
      "year": 2019,
      "citationCount": 813,
      "doi": "10.1056/nejmoa1815281",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1815281",
      "verified": true
    },
    {
      "title": "Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study",
      "journal": "The Lancet Oncology",
      "year": 2016,
      "citationCount": 781,
      "doi": "10.1016/s1470-2045(16)30019-5",
      "sourceUrl": "https://doi.org/10.1016/s1470-2045(16)30019-5",
      "verified": true
    },
    {
      "title": "Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study",
      "journal": "The Lancet Regional Health - Europe",
      "year": 2021,
      "citationCount": 737,
      "doi": "10.1016/j.lanepe.2021.100122",
      "sourceUrl": "https://doi.org/10.1016/j.lanepe.2021.100122",
      "verified": true
    },
    {
      "title": "Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process",
      "journal": "Blood",
      "year": 1998,
      "citationCount": 736,
      "doi": "10.1182/blood.v91.1.3",
      "sourceUrl": "https://doi.org/10.1182/blood.v91.1.3",
      "verified": true
    },
    {
      "title": "Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial",
      "journal": "Blood",
      "year": 2015,
      "citationCount": 691,
      "doi": "10.1182/blood-2015-06-651125",
      "sourceUrl": "https://doi.org/10.1182/blood-2015-06-651125",
      "verified": true
    },
    {
      "title": "Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial",
      "journal": "The Lancet",
      "year": 2012,
      "citationCount": 621,
      "doi": "10.1016/s0140-6736(11)61940-5",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(11)61940-5",
      "verified": true
    },
    {
      "title": "First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial",
      "journal": "The Lancet Oncology",
      "year": 2016,
      "citationCount": 613,
      "doi": "10.1016/s1470-2045(16)30051-1",
      "sourceUrl": "https://doi.org/10.1016/s1470-2045(16)30051-1",
      "verified": true
    },
    {
      "title": "Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",
      "journal": "Annals of Oncology",
      "year": 2015,
      "citationCount": 590,
      "doi": "10.1093/annonc/mdv303",
      "sourceUrl": "https://doi.org/10.1093/annonc/mdv303",
      "verified": true
    },
    {
      "title": "<i>TP53</i> Mutation and Survival in Chronic Lymphocytic Leukemia",
      "journal": "Journal of Clinical Oncology",
      "year": 2010,
      "citationCount": 586,
      "doi": "10.1200/jco.2009.27.8762",
      "sourceUrl": "https://doi.org/10.1200/jco.2009.27.8762",
      "verified": true
    },
    {
      "title": "Extracellular vesicle measurements with nanoparticle tracking analysis – An accuracy and repeatability comparison between NanoSight NS300 and ZetaView",
      "journal": "Journal of Extracellular Vesicles",
      "year": 2019,
      "citationCount": 586,
      "doi": "10.1080/20013078.2019.1596016",
      "sourceUrl": "https://doi.org/10.1080/20013078.2019.1596016",
      "verified": true
    },
    {
      "title": "Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",
      "journal": "Annals of Oncology",
      "year": 2020,
      "citationCount": 542,
      "doi": "10.1016/j.annonc.2020.09.019",
      "sourceUrl": "https://doi.org/10.1016/j.annonc.2020.09.019",
      "verified": true
    },
    {
      "title": "COVID‐19 associated pulmonary aspergillosis",
      "journal": "Mycoses",
      "year": 2020,
      "citationCount": 534,
      "doi": "10.1111/myc.13096",
      "sourceUrl": "https://doi.org/10.1111/myc.13096",
      "verified": true
    },
    {
      "title": "Treatment of Older Patients with Mantle-Cell Lymphoma",
      "journal": "New England Journal of Medicine",
      "year": 2012,
      "citationCount": 510,
      "doi": "10.1056/nejmoa1200920",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1200920",
      "verified": true
    },
    {
      "title": "Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial",
      "journal": "Blood",
      "year": 2014,
      "citationCount": 501,
      "doi": "10.1182/blood-2014-01-546150",
      "sourceUrl": "https://doi.org/10.1182/blood-2014-01-546150",
      "verified": true
    },
    {
      "title": "Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment",
      "journal": "American Journal of Hematology",
      "year": 2019,
      "citationCount": 490,
      "doi": "10.1002/ajh.25595",
      "sourceUrl": "https://doi.org/10.1002/ajh.25595",
      "verified": true
    },
    {
      "title": "Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine",
      "journal": "Blood",
      "year": 2005,
      "citationCount": 485,
      "doi": "10.1182/blood-2005-02-0642",
      "sourceUrl": "https://doi.org/10.1182/blood-2005-02-0642",
      "verified": true
    },
    {
      "title": "Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial",
      "journal": "Journal of Clinical Oncology",
      "year": 2012,
      "citationCount": 444,
      "doi": "10.1200/jco.2011.36.9348",
      "sourceUrl": "https://doi.org/10.1200/jco.2011.36.9348",
      "verified": true
    },
    {
      "title": "Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group",
      "journal": "Journal of Clinical Oncology",
      "year": 2012,
      "citationCount": 429,
      "doi": "10.1200/jco.2011.39.2688",
      "sourceUrl": "https://doi.org/10.1200/jco.2011.39.2688",
      "verified": true
    },
    {
      "title": "Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study",
      "journal": "The Lancet Oncology",
      "year": 2015,
      "citationCount": 407,
      "doi": "10.1016/s1470-2045(15)00465-9",
      "sourceUrl": "https://doi.org/10.1016/s1470-2045(15)00465-9",
      "verified": true
    },
    {
      "title": "Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia",
      "journal": "Nature Genetics",
      "year": 2004,
      "citationCount": 404,
      "doi": "10.1038/ng1343",
      "sourceUrl": "https://doi.org/10.1038/ng1343",
      "verified": true
    },
    {
      "title": "Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2",
      "journal": "Nature Medicine",
      "year": 1999,
      "citationCount": 401,
      "doi": "10.1038/12491",
      "sourceUrl": "https://doi.org/10.1038/12491",
      "verified": true
    },
    {
      "title": "International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia",
      "journal": "Leukemia",
      "year": 2007,
      "citationCount": 396,
      "doi": "10.1038/sj.leu.2404584",
      "sourceUrl": "https://doi.org/10.1038/sj.leu.2404584",
      "verified": true
    },
    {
      "title": "Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network",
      "journal": "The Lancet",
      "year": 2016,
      "citationCount": 388,
      "doi": "10.1016/s0140-6736(16)00739-x",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(16)00739-x",
      "verified": true
    },
    {
      "title": "Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus",
      "journal": "Leukemia",
      "year": 2006,
      "citationCount": 381,
      "doi": "10.1038/sj.leu.2404441",
      "sourceUrl": "https://doi.org/10.1038/sj.leu.2404441",
      "verified": true
    },
    {
      "title": "Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group",
      "journal": "Journal of Clinical Oncology",
      "year": 2011,
      "citationCount": 371,
      "doi": "10.1200/jco.2010.33.8061",
      "sourceUrl": "https://doi.org/10.1200/jco.2010.33.8061",
      "verified": true
    },
    {
      "title": "Immunochemotherapy With Rituximab and Overall Survival in Patients With Indolent or Mantle Cell Lymphoma: A Systematic Review and Meta-analysis",
      "journal": "JNCI Journal of the National Cancer Institute",
      "year": 2007,
      "citationCount": 364,
      "doi": "10.1093/jnci/djk152",
      "sourceUrl": "https://doi.org/10.1093/jnci/djk152",
      "verified": true
    },
    {
      "title": "Chronic lymphocytic leukaemia",
      "journal": "The Lancet",
      "year": 2018,
      "citationCount": 359,
      "doi": "10.1016/s0140-6736(18)30422-7",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(18)30422-7",
      "verified": true
    },
    {
      "title": "Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures",
      "journal": "American Journal of Hematology",
      "year": 2021,
      "citationCount": 358,
      "doi": "10.1002/ajh.26367",
      "sourceUrl": "https://doi.org/10.1002/ajh.26367",
      "verified": true
    },
    {
      "title": "Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network",
      "journal": "Journal of Clinical Oncology",
      "year": 2016,
      "citationCount": 344,
      "doi": "10.1200/jco.2015.63.8387",
      "sourceUrl": "https://doi.org/10.1200/jco.2015.63.8387",
      "verified": true
    },
    {
      "title": "The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity",
      "journal": "Journal of General Virology",
      "year": 2002,
      "citationCount": 340,
      "doi": "10.1099/0022-1317-83-5-973",
      "sourceUrl": "https://doi.org/10.1099/0022-1317-83-5-973",
      "verified": true
    },
    {
      "title": "Human Leukocyte Antigen-B-Associated Transcript 3 Is Released from Tumor Cells and Engages the NKp30 Receptor on Natural Killer Cells",
      "journal": "Immunity",
      "year": 2007,
      "citationCount": 337,
      "doi": "10.1016/j.immuni.2007.10.010",
      "sourceUrl": "https://doi.org/10.1016/j.immuni.2007.10.010",
      "verified": true
    },
    {
      "title": "Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study",
      "journal": "The Lancet Oncology",
      "year": 2016,
      "citationCount": 334,
      "doi": "10.1016/s1470-2045(16)30212-1",
      "sourceUrl": "https://doi.org/10.1016/s1470-2045(16)30212-1",
      "verified": true
    },
    {
      "title": "First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia",
      "journal": "Blood",
      "year": 2009,
      "citationCount": 333,
      "doi": "10.1182/blood-2009-02-206185",
      "sourceUrl": "https://doi.org/10.1182/blood-2009-02-206185",
      "verified": true
    },
    {
      "title": "Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial",
      "journal": "The Lancet Oncology",
      "year": 2020,
      "citationCount": 319,
      "doi": "10.1016/s1470-2045(20)30443-5",
      "sourceUrl": "https://doi.org/10.1016/s1470-2045(20)30443-5",
      "verified": true
    },
    {
      "title": "Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial",
      "journal": "Journal of Clinical Oncology",
      "year": 2018,
      "citationCount": 305,
      "doi": "10.1200/jco.2017.76.6840",
      "sourceUrl": "https://doi.org/10.1200/jco.2017.76.6840",
      "verified": true
    },
    {
      "title": "Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial",
      "journal": "Blood",
      "year": 2010,
      "citationCount": 302,
      "doi": "10.1182/blood-2010-03-275420",
      "sourceUrl": "https://doi.org/10.1182/blood-2010-03-275420",
      "verified": true
    },
    {
      "title": "Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial",
      "journal": "Blood",
      "year": 2009,
      "citationCount": 282,
      "doi": "10.1182/blood-2009-05-224071",
      "sourceUrl": "https://doi.org/10.1182/blood-2009-05-224071",
      "verified": true
    },
    {
      "title": "Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia",
      "journal": "Blood",
      "year": 2005,
      "citationCount": 281,
      "doi": "10.1182/blood-2005-05-2093",
      "sourceUrl": "https://doi.org/10.1182/blood-2005-05-2093",
      "verified": true
    },
    {
      "title": "Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment",
      "journal": "American Journal of Hematology",
      "year": 2017,
      "citationCount": 275,
      "doi": "10.1002/ajh.24826",
      "sourceUrl": "https://doi.org/10.1002/ajh.24826",
      "verified": true
    },
    {
      "title": "Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia",
      "journal": "Blood",
      "year": 2014,
      "citationCount": 274,
      "doi": "10.1182/blood-2014-02-556399",
      "sourceUrl": "https://doi.org/10.1182/blood-2014-02-556399",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5076077834",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Chronic_lymphocytic_leukemia.jpg/330px-Chronic_lymphocytic_leukemia.jpg"
}